Cargando…
Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe
On the basis of scientific evidence, information on the option, recommendation or requirement to test for pharmacogenetic or pharmacogenomic biomarkers is incorporated in the Summary of Product Characteristics of an increasing number of drugs in Europe. A screening of the Genetic Testing Registry (G...
Autores principales: | Huebner, Tatjana, Steffens, Michael, Scholl, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766366/ https://www.ncbi.nlm.nih.gov/pubmed/34905151 http://dx.doi.org/10.1007/s40291-021-00567-x |
Ejemplares similares
-
Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe
por: Huebner, Tatjana, et al.
Publicado: (2021) -
Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling
por: Huebner, Tatjana, et al.
Publicado: (2023) -
Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022) -
A New Approach to Psychiatric Drug Approval in Europe
por: Barbui, Corrado, et al.
Publicado: (2013) -
Molecular Cancer Genetics in Eastern and Central Europe
por: Olah, Edith
Publicado: (1999)